bladder cancer

by The Mount Sinai Hospital edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive form of the disease traditionally […]

Groundbreaking study published in The Journal of Molecular Diagnostics paves the way for noninvasive screening tools that improve patient comfort and outcomes Peer-Reviewed Publication Elsevier image: Groundbreaking research in The Journal of Molecular Diagnostics shows that analysis of specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer.

by PHIRE team edited by Lisa Lock, reviewed by Robert Egan Biomarker in human and dog bladder Credit: PHIRE Bladder cancer is a painful and often recurring disease, not just for humans, but for our canine companions as well. Urothelial carcinoma, the most common type of bladder cancer, affects both species in remarkably similar ways—from the genetics

  by Weill Cornell Medical College edited by Gaby Clark, reviewed by Robert Egan   Graphical abstract. Credit: Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.05.002 More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer. Now, a team of